Globus Medical (GMED) Tops Q2 EPS by 4c, beats revenue

Globus Medical (NYSE: GMED) reported Q2 EPS of $0.63, $0.04 better than the analyst estimate of $0.59. Revenue for the quarter came in at $291.62 million versus the consensus estimate of $279.53 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• RCM Technologies (RCMT) Tops Q2 EPS by 17c